Her postoperative course was complicated by suicidal ideations requiring a one-to-one sitter.
Dialysis was initiated on [**7-7**] with continued improvement in mental status.
The patient was initially treated conservatively for an myocardial infarction with heparin, beta blocker, aspirin, ACE inhibitor.
In the catheterization, the patient was discovered to have three-vessel disease and underwent percutaneous transluminal coronary angioplasty of Obtuse marginal 1 lesion with good results.
Coronary artery disease status post myocardial infarction on [**7-9**]; catheterization on [**7-12**] with percutaneous transluminal coronary angioplasty to obtuse marginal.
Tracheal stenosis, status post tracheostomy in [**2126**].
Aspirin 325 mg p.o.
NPH 5 units q. a.m.; 1 unit q. p.m. 3.
Protonix 40 mg p.o.
Calcium bicarbonate 500 mg p.o.
Rocaltrol 0.25 micrograms p.o.
Captopril 6.25 mg p.o.
Imdur 30 mg p.o.
Iron sulfate 325 mg p.o.
Colace 100 mg p.o.
Lopressor 50 mg p.o.
Zoloft 50 mg p.o.
Integrilin drip.
Per catheterization report, the patient has a severe three-vessel coronary artery disease, moderate to severe pulmonary hypertension, and successful percutaneous transluminal coronary angioplasty of the obtuse marginal 1.
Therefore, the patient was evaluated by a Transplant consultation for the placement of an AV fistula.
They recommended performing this procedure at a later date after the patient fully recovers from catheterization.
The patient's renal issues:  The patient continued to have acute on chronic renal failure and will require hemodialysis at the rehabilitation facility.
Hematologically, the patient's anemia has been stable and hematocrit post-catheterization was unchanged.
In the rehabilitation, the patient will need PET and Conair bed for her sacral and decubitus ulcers.
Aspirin 325 mg p.o.
NPH 5 units q. a.m. and 1 unit q. p.m. 3.
Protonix 40 mg p.o.
TUMS 500 mg p.o.
Imdur 30 mg p.o.
Iron sulfate 225 mg p.o.
Lopressor 50 mg p.o.
Colace 100 mg p.o.
Zoloft 50 mg p.o.
Atorvastatin 20 mg p.o.
Heparin 1000 units subcutaneously twice a day.
Rocaltrol 0.25 micrograms p.o.
The patient is not on an ACE inhibitor secondary to her renal failure.
The patient will require hemodialysis as an outpatient.
